Free Trial
→ Genesis 14:13-17 [HIDDEN MEANING?] (From Paradigm Press) (Ad) Free ADPT Stock Alerts

Adaptive Biotechnologies (ADPT) SEC Filings & 10K Form

Adaptive Biotechnologies logo
$10.75 +0.09 (+0.84%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$10.76 +0.01 (+0.09%)
As of 07/25/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Adaptive Biotechnologies SEC Filings

Export to Excel
DateFilerForm TypeView
06/12/2025
3:51 PM		Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
12:40 PM		Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
05/20/2025
6:46 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4/A
05/19/2025
6:59 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
9:34 AM		Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G
05/07/2025
10:42 AM		Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
05/01/2025
4:38 PM		Adaptive Biotechnologies (Subject)
ROBINS HARLAN S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
3:15 PM		Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:13 PM		Adaptive Biotechnologies (Filer)
Form ARS
03/26/2025
5:48 PM		Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:45 PM		Adaptive Biotechnologies (Subject)
ROBINS HARLAN S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
6:33 PM		Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:34 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
4:28 PM		Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
6:48 PM		Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:47 PM		Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
4:30 PM		Adaptive Biotechnologies (Subject)
HERSHBERG ROBERT (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
1:48 PM		Adaptive Biotechnologies (Subject)
NEUPERT PETER M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
6:14 PM		Adaptive Biotechnologies (Issuer)
GRIFFIN MICHELLE RENEE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:15 PM		Adaptive Biotechnologies (Issuer)
HERSHBERG ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:16 PM		Adaptive Biotechnologies (Issuer)
NEUPERT PETER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:16 PM		Adaptive Biotechnologies (Issuer)
OWEN KATEY EINTERZ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:17 PM		Adaptive Biotechnologies (Issuer)
Pellini Michael J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:17 PM		Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:18 PM		Adaptive Biotechnologies (Issuer)
ROBINS HARLAN S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:19 PM		Adaptive Biotechnologies (Issuer)
RUBINSTEIN JULIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:20 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:21 PM		Adaptive Biotechnologies (Issuer)
BENZENO SHARON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:22 PM		Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
6:22 PM		Adaptive Biotechnologies (Issuer)
LO FRANCIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:10 PM		Adaptive Biotechnologies (Subject)
GRIFFIN MICHELLE RENEE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:36 PM		Adaptive Biotechnologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
6:28 PM		Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:51 PM		Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
7:21 PM		Adaptive Biotechnologies (Issuer)
ROBINS CHAD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
10:23 AM		Adaptive Biotechnologies (Subject)
ARK Investment Management LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:11 PM		Adaptive Biotechnologies (Subject)
ROBINS CHAD M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
1:20 PM		Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SCHEDULE 13G/A
02/04/2025
5:13 AM		Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SCHEDULE 13G/A
01/27/2025
3:00 PM		Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G/A
11/19/2024
5:45 PM		Adaptive Biotechnologies (Issuer)
PISKEL KYLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
If you saw this, you'd be scared too (Ad)

Markets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ years of navigating crashes and crises, he says traditional strategies could soon become wealth destroyers. A time-sensitive briefing reveals what to do now.

Watch his urgent warning before this “dark day” hits
11/13/2024
3:30 PM		Adaptive Biotechnologies (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/13/2024
8:00 AM		Adaptive Biotechnologies (Subject)
Matrix Capital Management Company, LP (Filed by)
Form SC 13G/A
11/12/2024
12:30 PM		Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
2:15 PM		Adaptive Biotechnologies (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
11/07/2024
3:30 PM		Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
5:07 AM		Adaptive Biotechnologies (Subject)
Sumitomo Mitsui Trust Group, Inc. (Filed by)
Form SC 13G
11/04/2024
9:58 AM		Adaptive Biotechnologies (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/11/2024
3:14 PM		Adaptive Biotechnologies (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
10/10/2024
4:47 PM		Adaptive Biotechnologies (Issuer)
BOBULSKY SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:27 PM		Adaptive Biotechnologies (Issuer)
Taylor Stacy L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:18 PM		Adaptive Biotechnologies (Subject)
Taylor Stacy L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:30 PM		Adaptive Biotechnologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:15 PM		Adaptive Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ADPT) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners
Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...
InvestorPlace | Sponsored
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...
Brownstone Research | Sponsored
BITCOIN
Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....
Awesomely, LLC | Sponsored
Strait of Hormuz = $100 Oil?
Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...
The Oxford Club | Sponsored
URGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?
According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...
Paradigm Press | Sponsored
Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...
Altimetry | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored